Publication | Open Access
A phase III trial of empiric chemotherapy with cisplatin and gemcitabine or systemic treatment tailored by molecular gene expression analysis in patients with carcinomas of an unknown primary (CUP) site (GEFCAPI 04)
240
Citations
0
References
2019
Year
Malignant DiseaseMedicinePhase Iii TrialPathologyMetronomic ChemotherapyCancer TreatmentOncologyRadiation OncologyEmpiric ChemotherapyTumor BiologyGefcapi 04
No additional data available for this publication yet. Check back later!